It was shown that in T1D, insulin and its precursor, preproinsulin, are major self-antigens targeted by T cells [12], and it was reported that patients with diabetes carrying the PTPN22R620W genetic variant showed higher levels of insulin autoantibodies (IAAs) [13]. This evidence concerns the gene INS and diabetes mellitus.